People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SyntheX,Inc. | — | Biotechnology | Series A | $10.1M | $34.7M | 2023 |
| Cellens, Inc. | — | Other Health Care | Series A | $7.0M | $20.7M | 2025 |
Mohan Iyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mohan Iyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arvind Gupta | 1 | 3 |
| Jesse Salk | 1 | 3 |
| Lena Chaihorsky-Hering | 1 | 1 |
| Phuong (Jean) Pham | 1 | 1 |
| Phuong Nhu Pham | 1 | 1 |
| Charly Chahwan | 1 | 1 |
| Maria Soloveychik | 1 | 1 |
| Deborah Zajac | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.